We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The First Discovery of a Single Digit Nanomolar Small Molecule Blocker of a Protein-protein Interaction Target

Video   Jul 03, 2015

 



About the Speaker
Dr. Nils Hansen is the CEO and founder of Vipergen ApS. He is the principal inventor of the enabling YoctoReactor® and Binder Trap Enrichment® drug discovery technology platforms. He previously worked for Praecis Pharmaceuticals Inc., (Waltham, MA, USA) and Symphogen A/S, (Copenhagen, Denmark). Dr. Hansen earned his Ph.D. in immunology from the University of Copenhagen, Denmark in 2000 and his M.Sc. in Chemistry and Biotechnology from the University of Aarhus, Denmark in 1996.Abstract
Effective small molecule PPI blocker discovery using high fidelity DNA-encoded libraries and a low-noise homogeneous screening assay. The screen employs a unique principle of trapping small molecule binders together with the protein target in miniscule droplets.

 
 
 
 

Recommended Videos

A Voice for Diversity in Science

Video

Only 17% of the English-language biographies on Wikipedia are about women – but the statistic won’t stay that low for long if Dr Jess Wade has her way. A passionate advocate for diversity in science, Jess balances her work as an award-winning physicist at Imperial College London with her role as a ‘Wikipedian’, creating and uploading the biographies of underrepresented groups in science.

WATCH NOW

Light Driven Fine Chemical Production in Yeast Biohybrids

Video

Wyss Institute Core Faculty member Neel Joshi explains the concept of yeast biohybrids and how they can be used to harvest energy from light to drive the production of fine chemicals.

WATCH NOW

Analysing the pathophysiological role played by VEGFR2 and CXCR4

Video

Laura Kilpatrick, Chloe Peach and Carl White from the University of Nottingham talk about Cancer Research and how they use our Microplate Readers PHERAstar and CLARIOstar.

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE